At Current Prices, TC BioPharm (Holdings) plc ADR (NASDAQ: TCBP) Worth A Patient Look?

TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP)’s traded shares stood at 0.33 million during the latest session, with the company’s beta value hitting 0.12. At the last check today, the stock’s price was $1.97, to imply a decrease of -0.51% or -$0.01 in intraday trading. The TCBP share’s 52-week high remains $138.00, putting it -6905.08% down since that peak but still an impressive 4.06% since price per share fell to its 52-week low of $1.89. The company has a valuation of $0.63M, with an average of 1.88 million shares in intraday trading volume over the past 10 days and average of 520.10K shares over the past 3 months.

TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP) trade information

After registering a -0.51% downside in the latest session, TC BioPharm (Holdings) plc ADR (TCBP) has traded red over the past five days. The 5-day price performance for the stock is -61.07%, and -66.44% over 30 days. With these gigs, the year-to-date price performance is -93.79%. Short interest in TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP) saw shorts transact 19179.0 shares and set a 0.05 days time to cover.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

TCBP Dividends

TC BioPharm (Holdings) plc ADR has its next earnings report out on 2022-Dec-12. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP)’s Major holders

TC BioPharm (Holdings) plc ADR insiders hold 0.01% of total outstanding shares, with institutional holders owning 3.30% of the shares at 3.30% float percentage. In total, 3.30% institutions holds shares in the company.

Going by data provided on Aug 31, 2022, Trust For Professional Managers-PMC Diversified Equity Fund holds roughly 19.07 shares. This is just over 0.05% of the total shares, with a market valuation of $37373.0